Back to top

Analyst Blog

Health Net, Inc. (HNT - Analyst Report) is set to report fourth-quarter 2013 results on Feb 11. Last quarter, it posted a 40.68% positive surprise. Let’s see how things are shaping up for this announcement.

Factors this Past Quarter

In order to enhance its membership base, Health Net has been spreading awareness about diabetes among Americans aged 65 and above.  Health Net also collaborated with the Centers for Medicare & Medicaid Services (CMS) and the California Department of Health Care Services (DHCS) to build awareness and improve health conditions of the dual-eligibles in Los Angeles and San Diego. These initiatives are expected to help Health Net achieve a 2–3% increase in Medicare Advantage enrollment and a 4–6% rise in Medicaid enrollment in 2013. Moreover, the company’s foray into Arizona Medicaid in the last quarter is expected to enhance customer base and hence revenue generation.

However, declining revenues from Health Net’s government contracts segment over the past few years is a concern, as the company generates a substantial part of its revenues from this segment. Adding to the woes, the ongoing uncertainties in the global economy and challenging market conditions like high levels of unemployment, diminished consumer confidence and volatility in both the U.S. and international capital and credit markets might weigh on the company’s profitability in the fourth quarter.

Earnings Whispers?

Our proven model does not conclusively show that Health Net is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP (Expected Surprise Prediction) and a Zacks Rank #1, 2 or 3 for this to happen. That is not the case here as you will see below.

Zero Zacks ESP:  That is because both the Most Accurate estimate and the Zacks Consensus Estimate stand at 28 cents. That is a difference of 0.00%.

Zacks Rank #3 (Hold): Health Net’s Zacks Rank #3 increases the predictive power of ESP but when combined with a zero ESP makes surprise prediction difficult. We caution against stocks with Zacks Rank #4 and 5 (Sell-rated stocks) going into the earnings announcement, especially when the company is witnessing negative or zero estimate revisions momentum.

Other Stocks to Consider

Here are some other companies you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:  

HEALTHSOUTH Corp. (HLS - Snapshot Report), with Earnings ESP of +4.55% and Zacks Rank #3.

PharMerica Corporation (PMC - Snapshot Report), with Earnings ESP of +9.09% and Zacks Rank #3.

Tenet Healthcare Corp. (THC - Analyst Report), with Earnings ESP of +17.65% and Zacks Rank #3.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
STRATTEC SE… STRT 80.24 +3.00%
PATTERSON-U… PTEN 34.54 +2.98%